Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1001/archinte.1977.03630210171054 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Anamnesis Checklist for Informed Oral Contraceptive Choices: A Spanish Perspective.
Womens Health Rep (New Rochelle)
January 2025
Hospital Nuestra Señora de Fátima, Vithas Vigo, Vigo, Spain.
Objectives: This study aimed to develop an anamnesis checklist for oral contraceptive (OC) choice focused on their safety profile and associated risk factors.
Study Design: This study involved eight health care professionals in Spain, including six gynecologists and two internists, selected for their expertise in contraception counseling. We employed the design-thinking process, structured in five phases: empathizing with patients' needs, defining key areas of impact, devising innovative solutions, prototyping ideas into testable proposals, and validating prototypes.
Primary care in the COVID-19 pandemic and beyond: Lessons from Ontario.
Can Fam Physician
January 2025
Vice-Chair of Quality and Innovation in the DFCM at U of T; Associate Professor in the Faculty of Medicine and the Institute of Health Policy, Management and Evaluation at U of T; Scientist in the MAP Centre for Urban Health Solutions at St Michael's Hospital; and a staff physician in the DFCM at St Michael's Hospital, Unity Health Toronto.
Objective: To understand the role of primary care in the COVID-19 pandemic to provide insight into its functioning and inform potential reforms.
Composition Of The Committee: The now dissolved Ontario COVID-19 Science Advisory Table (Science Table) was formed in July 2020 to provide decision makers and the public with a synthesis of rapidly evolving evidence related to COVID-19. The Science Table was based at the Dalla Lana School of Public Health at the University of Toronto, and supported by Public Health Ontario.
Poor communication impairs optimal care of patients with heart failure and erectile dysfunction.
ESC Heart Fail
January 2025
MediCordis, Altenburg, Germany.
Aims: Heart failure (HF) and erectile dysfunction (ED) share numerous risk factors and pathogenetic mechanisms, resulting in a high prevalence of ED among male patients with HF. This questionnaire-based study aimed to better understand the patient's journey from a patient perspective and that of healthcare professionals (HCPs) regarding communication, education and treatment of ED as a recognized comorbid condition.
Methods: Two independent online surveys were conducted between November 2021 and January 2022 in Germany.
Treatment of Venous Thromboembolism with Edoxaban over 18 Months: Results from ETNA-VTE Europe.
Thromb Haemost
January 2025
Guy's and St Thomas' NHS Foundation Trust, King's College London, United Kingdom.
Background: The benefits and risks of extending anticoagulant treatment beyond the first 3 to 6 months in patients with venous thromboembolism (VTE) in clinical practice are not well understood.
Methods: ETNA-VTE Europe is a prospective, noninterventional, post-authorization study in unselected patients with VTE treated with edoxaban in eight European countries for up to 18 months. Recurrent VTE, major bleeding, and all-cause death were the primary study outcomes.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!